Literature DB >> 2319467

Effect of dose on nicotine's reinforcing, withdrawal-suppression and self-reported effects.

J R Hughes1, S W Gust, R M Keenan, J W Fenwick.   

Abstract

Seventy-eight smokers trying to quit were randomly assigned to 0-, 0.5-, 2- and 4-mg doses of nicotine gum and tracked for 9 months. In the 1st week of abstinence, self-administration of gum did not differ by dose (4 mg = 2 mg = 0.5 mg = 0 mg). Higher doses did not more effectively suppress withdrawal than lower doses nor induce more accurate nicotine identification (4 mg = 2 mg = 0.5 mg greater than 0 mg). Higher doses slightly increased ratings of adverse effects in the 1st week (4 mg greater than 2 mg greater than 0.5 mg greater than 0 mg). Over the next 6 months, the two higher doses appeared to support more gum self-administration than the two lower doses (4 mg = 2 mg greater than 0.5 mg = 0 mg) in the subsample of long-term quitters (n = 20). Our results suggest the dose-response curves differ for nicotine gum's reinforcing, withdrawal-suppression and self-reported effects.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2319467

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  11 in total

1.  Prolonged nicotine dependence associated with extended access to nicotine self-administration in rats.

Authors:  Neil E Paterson; Athina Markou
Journal:  Psychopharmacology (Berl)       Date:  2004-01-08       Impact factor: 4.530

2.  Transdermal nicotine-induced tobacco abstinence symptom suppression: nicotine dose and smokers' gender.

Authors:  Sarah E Evans; Melissa Blank; Cynthia Sams; Michael F Weaver; Thomas Eissenberg
Journal:  Exp Clin Psychopharmacol       Date:  2006-05       Impact factor: 3.157

3.  If the data contradict the theory, throw out the data: Nicotine addiction in the 2010 report of the Surgeon General.

Authors:  Hanan Frenk; Reuven Dar
Journal:  Harm Reduct J       Date:  2011-05-19

4.  Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation.

Authors:  Nicola Lindson; Samantha C Chepkin; Weiyu Ye; Thomas R Fanshawe; Chris Bullen; Jamie Hartmann-Boyce
Journal:  Cochrane Database Syst Rev       Date:  2019-04-18

5.  Nicotine discrimination in male and female smokers.

Authors:  K A Perkins; A DiMarco; J E Grobe; A Scierka; R L Stiller
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

Review 6.  Molecules and circuits involved in nicotine addiction: The many faces of smoking.

Authors:  Marina R Picciotto; Yann S Mineur
Journal:  Neuropharmacology       Date:  2013-04-28       Impact factor: 5.250

Review 7.  Tobacco addiction.

Authors:  Dorothy K Hatsukami; Lindsay F Stead; Prakash C Gupta
Journal:  Lancet       Date:  2008-06-14       Impact factor: 79.321

8.  Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation. A systematic review and meta-analysis of one hundred and twenty studies involving 177,390 individuals.

Authors:  Edward J Mills; Ping Wu; Ian Lockhart; Kumanan Wilson; Jon O Ebbert
Journal:  Tob Induc Dis       Date:  2010-07-13       Impact factor: 2.600

Review 9.  Nicotine replacement therapy versus control for smoking cessation.

Authors:  Jamie Hartmann-Boyce; Samantha C Chepkin; Weiyu Ye; Chris Bullen; Tim Lancaster
Journal:  Cochrane Database Syst Rev       Date:  2018-05-31

10.  Activation of trace amine-associated receptor 1 attenuates nicotine withdrawal-related effects.

Authors:  Ruyan Wu; Jianfeng Liu; Bernard Johnson; Yufei Huang; Yanan Zhang; Jun-Xu Li
Journal:  Addict Biol       Date:  2021-06-25       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.